Calling Gilead's CAR-T infringement 'willful,' judge enhances BMS' award to $1.2B

In quick succession, Gilead Sciences has not only lost an early attempt to overturn a massive CAR-T patent infringement verdict, but now a judge has also ordered hundreds of millions of enhanced damages for plaintiff Bristol Myers Squibb.